ZEN Graphene Solutions Announces Successful Phase 2 Cytotoxicity Testing Results
This release was issued on March 2, 2021 and speaks only as of that date. It has not been updated. For Zentek’s current disclosure, see SEDAR+ and EDGAR.
The full text of this release is available on the wire service.